微信公众号

官网二维码

中国癌症防治杂志 ›› 2023, Vol. 15 ›› Issue (3): 298-303.doi: 10.3969/j.issn.1674-5671.2023.03.08

• 基础研究 • 上一篇    下一篇

复方山慈菇对人乳腺癌MDA⁃MB⁃231细胞裸鼠移植瘤生长的抑制作用及网络药理学分析

  

  1. 广西医科大学药学院;广西医科大学第四附属医院药学部;广西医科大学第一附属医院药学部
  • 出版日期:2023-06-25 发布日期:2023-06-19
  • 通讯作者: 陈祝英 E-mail:121255262@qq.com;何萍 E-mail: hpnngxmu@163.com
  • 基金资助:
    广西科技基础条件平台建设项目(15?235?06);广西医科大学大学生创新创业计划项目(202010598034)

Inhibitory effect of compound cremastra appendiculata on growth of human breast cancer MDA-MB-231 cell xenografts in nude mice and a network pharmacological analysis

  • Online:2023-06-25 Published:2023-06-19

摘要: 目的 探讨复方山慈菇对人乳腺癌MDA⁃MB⁃231细胞裸鼠移植瘤生长的抑制作用及其潜在的作用机制。方法 将人乳腺癌MDA⁃MB⁃231细胞裸鼠移植瘤模型随机分为模型组、阳性对照多柔比星(doxorubicin,DOX)组和复方山慈菇醇提物(compound cremastra appendiculata ethanol extraction,CCAEE)高剂量组(1.8 g/kg)以及低剂量组(0.9 g/kg),每组5只。按照分组连续灌胃给药21 d后,处死裸鼠并计算各组裸鼠移植瘤体积、重量和抑瘤率。采用TCMSP 2.3数据库选出复方山慈菇有效成分及其对应的作用靶点,OMIM、GeneCards 5.14、DrugBank 5.1.10、TTD数据库筛选关键靶点并利用STRING 11.5数据库构建蛋白质相互作用(PPI)网络,然后筛选核心靶点,以构建“药物⁃成分⁃靶点”网络并筛选出核心有效成分。利用Metascape 3.5平台进行GO和KEGG富集分析。结果 各组荷瘤裸鼠分别给药处理21 d后,与模型组比较,DOX组和CCAEE高、低剂量组裸鼠移植瘤体积、重量均明显减小(均P<0.05),抑瘤率分别为89.67%、67.39%和43.48%。通过网络药理学分析获得复方山慈菇有效成分27个,抗乳腺癌关键靶点108个,其中核心靶点23个,主要包括TP53、MAPK3、MAPK1、RELA、AKT1、FOS、ESR1、TNF、IL6、MAPK14等;核心有效成分5个,分别为槲皮素、山柰酚、β⁃谷甾醇、2⁃甲氧基⁃9,10⁃二氢菲⁃4,5⁃二醇、去氧鬼臼毒素。GO和KEGG富集分析显示复方山慈菇主要通过激素调节等生物过程以及PI3K⁃AKT、MAPK等信号通路发挥抗乳腺癌作用。 结论 复方山慈菇能抑制人乳腺癌移植瘤生长,其可能通过槲皮素、山柰酚等核心有效成分作用于TP53等核心靶点及PI3K⁃AKT、MAPK等信号通路而发挥抗乳腺癌作用。

关键词: 乳腺癌, 复方山慈菇, MDA?MB?231细胞, 裸鼠移植瘤, 网络药理学

Abstract: Objective To investigate the inhibitory effect of compound cremastra appendiculata on the growth of human breast cancer MDA⁃MB⁃231 cell xenografts in nude mice and its potential mechanism. Methods The nude mice of model human breast cancer MDA⁃MB⁃231 cell xenografts were randomly divided into model group, doxorubicin (DOX) group, compound cremastra appendiculata ethanol extraction (CCAEE) high⁃dose group (1.8 g/kg) and CCAEE low⁃dose group (0.9 g/kg), with 5 mice in each group. After 21 days of continuous drug administration, the nude mice were sacrificed, and the tumor volume, tumor weight and tumor inhibition rate were calculated. The effective components of compound cremastra appendiculata and their corresponding targets were selected from the TCMSP 2.3 database, and the key targets were screened from the OMIM, GeneCards 5.14, DrugBank 5.1.10 and TTD databases.The protein⁃protein interaction (PPI) network of key targets was constructed by STRING 11.5 database. Then, the core targets were screened to establish the "drug⁃component⁃target" network and screen the core effective components. GO and KEGG enrichment analyses were performed using the Metascape 3.5 platform. Results Compared with the model group, after the 21 days treatment, the tumor volume and weight of the nude mice in DOX group, CCAEE high⁃dose group and low⁃dose group were significantly reduced (all P<0.05), and the tumor inhibition rates were 89.67%, 67.39% and 43.48%, respectively. 27 effective ingredients of compound cremastra appendiculata and 108 key targets for against breast cancer were obtained through a network pharmacological analysis, including 23 core targets (TP53, MAPK3, MAPK1, RELA, AKT1, FOS, ESR1, TNF, IL6, MAPK14, etc.) and 5 core  effective components (quercetin, kaempferol, β⁃sitosterol, 2⁃methoxy⁃9, 10⁃dihydro⁃4, 5⁃diol, and deoxypodophyllotoxin). GO and KEGG enrichment analyses indicated that compound cremastra appendiculata showed its anti⁃breast cancer effect mainly through the regulation of the biological processes such as hormone regulation and the signaling pathways such as PI3K⁃AKT and MAPK. Conclusions Compound cremastra appendiculata can inhibit the growth of human breast cancer xenograft, probably by acting on core targets such as TP53 and signaling pathways such as PI3K⁃AKT and MAPK through core effective ingredients such as quercetin and kaempferol.


Key words:  Breast cancer, Compound cremastra appendiculata, MDA?MB?231 cells, Cancer xenograft in nude mice, Network pharmacology

中图分类号: 

  •